Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma

D. S. Carroll, R. J. Gralla, N. E. Kemeny

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences